- Mar 7, 2016

Scientists work to bring about a new treatment for rare childhood cancer

In a study featured on the cover of last month's edition of the journal Cancer Cell, Anthony Faber, Ph.D., and a team of scientists demonstrated that MYCN-amplified neuroblastoma cells are highly sensitive to an investigational drug called ABT-199 that is currently being evaluated in clinical trials for another disease.

World-first guidelines created to prevent heart complications in children during cancer treatment

Patient Activated Education Effective as Surveillance for Skin Cancer in Childhood Cancer Survivors

Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders

Low BMD, fracture risk upped in childhood cancer survivors

Understanding How Childhood Brain Tumors Develop

American Academy of Pediatrics Issues New Recommendations on Hospitalized Adolescents

Genes that cause rare hidden cancer revealed

Stopping a rare childhood cancer in its tracks

Pediatric Cancer Vaccine May Be ‘Too Good to Be True,’ But More Work Is Needed

New research identifies a potential treatment target for hepatoblastoma in children

Recent Posts

Scientists work to bring about a new treatment for rare childhood cancer

Archive

Search By Tags